Financials
Financial year 2025
Worth noting
- The team shrank two years in a row.
- Little cash and receivables against the short-term debts.
Revenue
€ 43.5 million
▲ 11% vs 2024
Profit
Growing€ 2.3 million
▲ 8% vs 2024
Debts
Low€ 10.8 million
▼ 7% vs 2024
DIDAK INJECTION from Grobbendonk, company number BE0428125831, closed financial year 2025 with a result of € 2.3 million after tax. For that financial year DIDAK INJECTION recorded revenue of € 43.5 million and equity of € 14.4 million. Compared with financial year 2024, the result moved from € 2.1 million to € 2.3 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
What happened at DIDAK INJECTION?
What happened at DIDAK INJECTION in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- SALDEC stepped down as director. NBB
- VANDEPUTTE-VALCKE stepped down as director. NBB
- DYNAMIC VOF stepped down as director. NBB
- ECNOEL stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 2.3 million (▲ 8% vs 2024). Source: NBB ↗
- VANDEPUTTE-VALCKE became a director. NBB
- DYNAMIC VOF became a director. NBB
- ECNOEL became a director. NBB
In short
From € 4.7 million profit in 2021 to € 2.3 million profit in 2025.
Paid € 4.9 million in corporate taxes since 2021.
Best year ever: 2021, with € 4.7 million profit.
Paid out € 13.2 million in dividends to the owners in total.
A new publication or filing at DIDAK INJECTION? We notify you, reason included.
Follow DIDAK INJECTIONNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Director · represented by Arnold Deceuninck, Alexander DECEUNINCK
Also active at: Edero, ECNOEL, Reyes Holding +5 more
since 2020 · until 2030
since 2024 · until 2030
since 2024 · until 2030
Managing director · represented by Alexander Deceuninck
Also active at: ANZIPLAST, HUNTER EN COLMAN, CASIER TRADING +1 more
since 2024 · until 2030
Establishments
Establishment units
Physical locations of this company
Industrieweg 1
2280 Grobbendonk
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Details
- Company number
- 0428.125.831
- VAT number
- BE 0428.125.831
- Registered office
- Industrieweg 1, 2280 Grobbendonk
- Names & denominations
- DIDAK INJECTION
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 2 January 1986
- Peppol
- Active · Active since 5 Jan 2026
- Activities · NACE
Vervaardiging van verpakkingsmateriaal van kunststof
Vervaardiging van andere producten van kunststof
Vervaardiging van overige producten van kunststof